Dietary exposure to brominated flame retardants and abnormal pap test results

Journal of Women's Health

Volumn 20, Issue 9, 2011, Pages 1269-1278

  Jamieson, Denise J ^a   Terrell, Metrecia L ^b   Aguocha, Nnenna N ^b   Small, Chanley M ^b   Cameron, Lorraine L ^c   Marcus, Michele ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAME RETARDANT; POLYBROMINATED BIPHENYL; POLYCHLORINATED BIPHENYL;

ADULT; AGE DISTRIBUTION; ARTICLE; BEEF; BREAST FEEDING; CIGARETTE SMOKING; COHORT ANALYSIS; DAIRY PRODUCT; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; ORAL CONTRACEPTION; PAPANICOLAOU TEST; POPULATION BASED CASE CONTROL STUDY; POULTRY; PRIORITY JOURNAL; REPRODUCTION; SELF REPORT; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANIMALS; BREAST FEEDING; COHORT STUDIES; CONTRACEPTIVES, ORAL; DAIRY PRODUCTS; DIET; FEMALE; FLAME RETARDANTS; FOOD CONTAMINATION; HUMANS; MEAT PRODUCTS; MICHIGAN; MIDDLE AGED; POLYBROMINATED BIPHENYLS; SMOKING; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS; YOUNG ADULT;

EID: 80053944675     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2010.2275     Document Type: Article

References (37)

1. Fries GF. The PBB episode in Michigan: An overall appraisal. Crit Rev Toxicol 1985;16:105-156.
2. Landrigan PJ, Wilcox KR Jr, Silva J Jr, Humphrey HE, Kauffman C, Heath CW Jr. Cohort study of Michigan residents exposed to polybrominated biphenyls: Epidemiologic and immunologic findings. Ann NY Acad Sci 1979;320:284-294.
3. Hoffman CS, Small CM, Blanck HM, Tolbert P, Rubin C, Marcus M. Endometriosis among women exposed to polybrominated biphenyls. Ann Epidemiol 2007;17:503-510. (Pubitemid 46950929)
4. Small CM, Cheslack-Postava K, Terrell M, et al. Risk of spontaneous abortion among women exposed to polybrominated biphenyls. Environ Res 2007;105:247-255. (Pubitemid 47368183)
5. Blanck HM, Marcus M, Tolbert PE, et al. Time to menopause in relation to PBBs, PCBs, and smoking. Maturitas 2004;49: 97-106. (Pubitemid 39330421)
6. Kaiser R, Marcus M, Blanck HM, et al. Polybrominated biphenyl exposure and benign breast disease in a cohort of U.S. women. Ann Epidemiol 2003;13:16-23. (Pubitemid 36120434)
7. Davis SI, Blanck HM, Hertzberg VS, et al. Menstrual function among women exposed to polybrominated biphenyls: A follow-up prevalence study. Environ Health a Global Access Sci Source. 2005;4:15.
8. Agency for Toxic Substances and Disease Registry. Toxicological profile for polybrominated biphenyls and polybrominated diphenyl ethers. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, 2004.
9. Juhasz AL, Smith E, Weber J. Brominated flame retardants- Safety at what cost? Lancet 2007;370:1813.
10. Blanck HM, Marcus M, Hertzberg V, et al. Determinants of polybrominated biphenyl serum decay among women in the Michigan PBB cohort. Environ Health Perspect 2000;108: 147-152. (Pubitemid 30153920)
11. Rosen DH, Flanders WD, Friede A, Humphrey HE, Sinks TH. Half-life of polybrominated biphenyl in human sera. Environ Health Perspect 1995;103:272-274.
12. Matthews HB, Dedrick RL. Pharmacokinetics of PCBs. Annu Rev Pharmacol Toxicol 1984;24:85-103. (Pubitemid 14129531)
13. Michalas SP. The Pap test: George N. Papanicolaou (1883- 1962). A screening test for the prevention of cancer of uterine cervix. Eur J Obstet Gynecol Reprod Biol 2000;90:135-138. (Pubitemid 30307526)
14. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-428. (Pubitemid 28135669)
15. Damstra T, Jurgelski W Jr, Posner HS, et al. Toxicity of polybrominated biphenyls (PBBs) in domestic and laboratory animals. Environ Health Perspect 1982;44:175-188. (Pubitemid 12007229)
16. Klumb EM, Araú jo ML, Jesus GR, et al. Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression? J Clin Rheumatol 2010;16:153-157.
17. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA: Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009;101:1120-1130.
18. American Cancer Society. What are the risk factors for cervical cancer? 2010. Available at www.cancer.org Accessed August 2010.
19. American College of Obstetricians and Gynecologists. Practice bulletin No. 35: Diagnosis and treatment of cervical carcinomas. Obstet Gynecol 2002;99:855-867.
20. Needham LL, Burse VW, Price HA. Temperatureprogrammed gas chromatographic determination of polychlorinated and polybrominated biphenyls in serum. J Assoc Off Anal Chem 1981;64:1131-1137.
21. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: Choice of the timescale. Am J Epidemiol 1997;145:72-80. (Pubitemid 27009060)
22. Thiebaut AC, Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: A simulation study. Stat Med 2004;23:3803-3820. (Pubitemid 40074078)
23. Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol 2000;96:219-223. (Pubitemid 30447342)
24. Benard VB, Eheman CR, Lawson HW, et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol 2004;103:564-571. (Pubitemid 40459074)
25. National Institutes of Health. Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res 1998;6(Suppl 2):51-209S.
26. Kreiss K. Studies on populations exposed to polychlorinated biphenyls. Environ Health Perspect 1985;60:193-199. (Pubitemid 15038901)
27. Howard M, Agarwal G, Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: A meta-analysis. Cancer Causes Control 2009;20: 1-13.
28. Newell S, Girgis A, Sanson-Fisher R, Ireland M. Accuracy of patients' recall of Pap and cholesterol screening. Am J Public Health 2000;90:1431-1435.
29. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervica/vaginal cytological diagnosis. JAMA 1989;262:931-934.
30. Collins Y, Einstein MH, Gostout BS, et al. Cervical cancer prevention in the era of prophylactic vaccines: A preview for gynecologic oncologists. Gynecol Oncol 2006;102:552-562. (Pubitemid 44354954)
31. Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Natl Rev Immunol 2004;4:46-54. (Pubitemid 38084131)
32. Silberhorn EM, Glauert HP, Robertson LW. Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. Crit Rev Toxicol 1990;20:440-496.
33. Crain DA, Janssen SJ, Edwards TM, et al. Female reproductive disorders: The roles of endocrine-disrupting compounds and developmental timing. Fertil Steril 2008;90: 911-940.
34. Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009;200:1059-1067.
35. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute, 2002. Available at seer.cancer.gov/csr/1973-1999/cervix.pdf
36. Winkelstein W Jr. Smoking and cervical cancer-Current status: A review. Am J Epidemiol 1990;131:945-957. (Pubitemid 20178615)
37. Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric casecontrol study. Lancet 2002;359:1085-1092. (Pubitemid 34270731)